The role of apoproteins in disorders of lipoprotein metabolism

Brown, 1983, Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic, J Clin Invest, 72, 743, 10.1172/JCI111044 Hui, 1986, Isolation and characterization of the apolipoprotein E receptor from canine and human liver, J Biol Chem, 261, 4256, 10.1016/S0021-9258(17)35655-7 Eisenberg, 1984, High density lipoprotein metabolism, J Lipid Res, 25, 1017, 10.1016/S0022-2275(20)37713-0 Thompson, 1984, Apoproteins: determinants of lipoprotein metabolism and indices of coronary risk, Br Heart J, 51, 585, 10.1136/hrt.51.6.585 Ball, 1986, Apoproteins: predictors of coronary heart disease?, Br Med J, 293, 769, 10.1136/bmj.293.6550.769 Naito, 1986, The clinical significance of apolipoprotein measurements, J Clin Immunoassay, 9, 11 Rees, 1987, DNA markers in the hyperlipidemias and atherosclerosis, J Royal Coll Phys, 721, 51 Breslow, 1985, Human apolipoprotein molecular biology and genetic variation, Ann Rev of Biochem, 54, 699, 10.1146/annurev.bi.54.070185.003411 Green, 1981, Intestinal lipoprotein metabolism, J Lipid Res, 22, 1153, 10.1016/S0022-2275(20)37308-9 Kane, 1980, Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons, 77, 2465 Kesaniemi, 1986, Intestinal cholesterol absorption in man is related to apolipoprotein E phenotype, J Clin Invest, 80, 578, 10.1172/JCI113107 Fielding, 1973, Kinetics of lipoprotein lipase activity: effects of the substrate apoprotein on reaction velocity, Biochim Biophys Acta, 316, 66, 10.1016/0005-2760(73)90167-7 McLeod, 1986, Purification of biologically active apolipoproteins by chromatofocusing, J Chrom, 381, 271, 10.1016/S0378-4347(00)83593-8 Utermann, 1984, Apolipoprotein E phenotypes and hyperlipidemia, Hum Genet, 65, 232, 10.1007/BF00286508 Utermann, 1986, The apo E-system: genetic control of plasma lipoprotein concentration, 261 Sing, 1985, Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation, Am J Hum Genet, 37, 268 Davignon, 1986, Importance of apolipoprotein E polymorphism in determining plasma lipid levels and atherosclerosis, 171 Breslow, 1986, Genetics of human apolipoproteins, Vol. 11, 85 Oram, 1986, Receptor mediated transport of cholesterol between cultured cells and high density lipoproteins, Method Enzymol, 129, 645, 10.1016/0076-6879(86)29096-5 Weisgraber, 1980, A-I Milano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoprotein, J Clin Invest, 66, 901, 10.1172/JCI109957 Utermann, 1982, Genetic variants of group A apolipoproteins. Rapid methods for screening and characterization without ultracentrifugation, J Biol Chem, 257, 501, 10.1016/S0021-9258(19)68392-4 Menzel, 1982, One step screening method for the polymorphism of apolipoproteins A-I, A-II, and A-IV, J Lipid Res, 23, 915, 10.1016/S0022-2275(20)38095-0 Menzel, 1984, Human apolipoprotein A-I polymorphism, J Biol Chem, 259, 3070, 10.1016/S0021-9258(17)43261-3 Rall, 1986, Identification of homozygosity for human apolipoprotein A-I variant, J Lipid Res, 27, 436, 10.1016/S0022-2275(20)38824-6 Frederickson, 1964, The inheritance of high density lipoprotein deficiency (Tangier Disease), J Clin Invest, 43, 228, 10.1172/JCI104907 Francheschini, 1980, A-I Milano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family, J Clin Invest, 66, 892, 10.1172/JCI109956 Gustafson, 1979, Identification of lipoprotein families in a variant of human plasma apolipoprotein A deficiency, Scand J Clin Lab Invest, 39, 377, 10.3109/00365517909106122 Carlson, 1979, Fish-eye disease. A new familial condition associated with massive corneal opacities and dyslipoproteinemia, Lancet, 8149, 921, 10.1016/S0140-6736(79)92621-7 Carlson, 1982, Fish-eye disease: a new familial condition with massive corneal opacities and dyslipoproteinemia, Eur J Clin Invest, 12, 41, 10.1111/j.1365-2362.1982.tb00938.x Vergani, 1981, Familial hypo-alpha-lipoproteinemia, Clin Chim Acta, 114, 45, 10.1016/0009-8981(81)90226-6 Third, 1984, Primary and familial hypoalphalipoproteinemia, Metabolism, 3, 136, 10.1016/0026-0495(84)90126-4 Byard, 1984, A genetic study of hypoalphalipoproteinemia, Genetic Epidemiology, 1, 43, 10.1002/gepi.1370010107 Ordovas, 1986, Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia, N Engl J Med, 314, 671, 10.1056/NEJM198603133141102 Norum, 1986, Clinical syndrome and lipid metabolism in hereditary deficiency of apolipoproteins AI and C-III, variant I, 137 Third, 1983, Normotriglyceridemic primary and familial hypoalphalipoproteinemia and coronary heart disease, Arteriosclerosis, 3, 486a Borecki, 1985, A major gene for primary hypoalphalipoproteinemia, Am J Hum Genet Rees, 1983, DNA polymorphism adjacent to the human apoprotein A-I gene: relation to hypertriglyceridemia, Lancet, 1, 444, 10.1016/S0140-6736(83)91440-X Hayden, 1987, DNA polymorphisms in and around the apo A-I-CIII genes and genetic hyperlipidemias, Am J Hum Genet, 40, 421 Karathanasis, 1983, An inherited polymorphism in the human apolipoprotein A-I gene locus related to the development of atherosclerosis, Nature, 301, 718, 10.1038/301718a0 Bassen, 1950, Malformation of the erythrocytes in a case of atypical retinitis pigmentosa, Blood, 5, 381, 10.1182/blood.V5.4.381.381 Scanu, 1974, A study of the abnormal lipoproteins in abetalipoproteinemia, J Clin Invest, 53, 440, 10.1172/JCI107578 Mars, 1969, Familial hypo-B-lipoproteinemia. A genetic disorder of lipid metabolism with nervous system involvement, Am J Med, 46, 886, 10.1016/0002-9343(69)90089-8 Cottrill, 1974, Familial homozygous hypobetalipoproteinemia, Metabolism, 23, 779, 10.1016/0026-0495(74)90010-9 Sniderman, 1980, Association of coronary atherosclerosis with hyperapobetalipoproteinemia (increased protein but normal cholesterol levels in human plasma low density (3) lipoproteins), 77, 604 Grundy, 1987, Familial combined hyperlipidemia workshop: meeting summary, 7, 203 Vega, 1987, Mechanisms of primary hypercholesterolemia in humans, Am Heart J, 113, 493, 10.1016/0002-8703(87)90620-X Breckenridge, 1978, Hypertriglyceridemia associated with deficiency of apolipoprotein C-II, N Engl J Med, 298, 1265, 10.1056/NEJM197806082982301 Yamamura, 1979, Familial type I hyperlipoproteinemia caused by apolipoprotein C-II deficiency, Atherosclerosis, 34, 53, 10.1016/0021-9150(79)90106-0 Miller, 1981, Familial apolipoprotein C-II deficiency: plasma lipoproteins and apolipoproteins in heterozygous and homozygous subjects and the effects of plasma infusion, Eur J Clin Invest, 11, 69, 10.1111/j.1365-2362.1981.tb01768.x Capurso, 1980, New case of apolipoprotein C-II deficiency, Lancet, 1, 268, 10.1016/S0140-6736(80)90768-0 Crepaldi, 1980, Lipoprotein and apoprotein, adipose tissue and hepatic lipoprotein lipase levels in patients with familial hyperchylomicronemia and their immediate family members Fellin, 1983, Familial lipoprotein lipase and apolipoprotein C-II deficiency, Atherosclerosis, 49, 55, 10.1016/0021-9150(83)90007-2 Stalenhoef, 1981, Combined deficiency of apolipoprotein C-II, and lipoprotein lipase in familial hyperchylomicronemia, Metabolism, 30, 919, 10.1016/0026-0495(81)90072-X Catapano, 1983, Plasma lipids, lipoproteins and apoproteins in a case of apo C-II deficiency, Clin Chim Acta, 130, 317, 10.1016/0009-8981(83)90306-6 Saku, 1984, C-II, an apolipoproteinemia and severe hypertriglyceridemia, Am J Med, 77, 457, 10.1016/0002-9343(84)90102-5 Fojo, 1985, Apolipoprotein C-II deficiency. Identification of two kindred with an abnormal apolipoprotein (apo) C-II, Clin Res, 33, 569A Hayden, 1986, The genetics and molecular biology of apolipoprotein C-II, 241 Utermann, 1977, Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinemia in man, Nature, 269, 604, 10.1038/269604a0 Gregg, 1986, The role of apolipoprotein E in modulating the metabolism of apolipoprotein B-48 and apolipoprotein B-100 containing lipoproteins in humans, 273 Innerarity, 1986, Type III hyperlipoproteinemia: a focus on lipoprotein receptor—apolipoprotein E2 interactions, 273 Ignatius, 1986, Expression of apolipoprotein E during nerve degeneration and regeneration, 83, 1125 Menzel, 1983, Apolipoprotein E polymorphism and coronary artery disease, Arteriosclerosis, 2, 310, 10.1161/01.ATV.3.4.310 Ghisseli, 1981, Type III hyperlipoproteinemia associated with apolipoprotein E deficiency, Science, 214, 1239, 10.1126/science.6795720 Boyles, 1986, Role for apolipoprotein E and A-I in nerve degeneration and regeneration (Abstract), Circulation, 74, II Maciejko, 1983, Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease, N Engl J Med, 309, 385, 10.1056/NEJM198308183090701 De Backer, 1986, Serum lipids and apoproteins in students whose parents suffered prematurely from a myocardial infarction, Am Heart J, 112, 478, 10.1016/0002-8703(86)90510-7 Freedman, 1986, The relation of apolipoproteins A-I and B in children to parental myocardial infarction, N Engl J Med, 315, 721, 10.1056/NEJM198609183151202 Kottke, 1986, Apolipoproteins and coronary artery disease, Mayo Clinic Proc, 61, 313, 10.1016/S0025-6196(12)61947-8 Miller, 1987, Associations of high-density lipoprotein sub-classes and apolipoproteins with ischemic heart disease and coronary atherosclerosis, Am Heart J, 113, 589, 10.1016/0002-8703(87)90638-7 Gaubatz, 1987, Isolation and characterization of the two major apoproteins in human lipoprotein (a), J Lipid Res, 28, 69, 10.1016/S0022-2275(20)38724-1 Hainline, 1986, Accuracy and comparability of long term measurements of cholesterol, Clin Chem, 32, 611, 10.1093/clinchem/32.4.611 Cooper, 1986, Interlaboratory testing of the transferability of a candidate reference method for total cholesterol in serum, Clin Chem, 32, 921, 10.1093/clinchem/32.6.921